B+
Bull case
25%
Probability
Target price
$58.80
Analysis reference price unavailable
Analysis 2026-01-31 · RankAlpha Sentiment AI
RPRX
RoyaltyDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Bull case: successful tuck-in acquisitions or above-consensus royalty inflows plus benign interest rates lift NAV multiples toward the analyst high; clinical/regulatory milestones for high-value assets are realized, supporting upside to or above the analyst high of $58.8 [#SERP-3].
Posture
Defensive
Lead driver
Value
What changed
2 setup hits (3d) with net bullish as of 2026-10-27.
What can break
Adverse clinical/regulatory outcomes for key royalty assets
Momentum
90
Value
62
Sentiment
29
Setup hits (3d)
2 · Net Bullish
AI TargetsBase $46.34 · Bull $58.80 · Bear $38.00Analysis 2026-01-31; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-27 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-31 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-10-27
Investment thesis
As of 2026-10-27
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-27. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Bullish
Target $66.00
Why
Momentum90 · Δ7d +17.3
Value62 · Δ7d -0.3
Sentiment29 · Δ7d -6.7
So what
Weak posture (Net Bullish). Prioritize risk control and patience.
Confirming evidence
- • 2 setup hits (3d) with net bullish as of 2026-10-27.
- • Value remains the lead driver in the composite, 7D delta -0.3.
Contradictions & invalidation
- • Adverse clinical/regulatory outcomes for key royalty assets
- • Execution risk on acquisitions and integration
- • Bear case: royalty revenue shortfalls, adverse clinical/regulatory outcomes for key assets, or interest-rate-driven multiple compression push shares below current levels toward the low analyst outcomes and nearer to $38 or lower (some sources show outlier lows) [#SERP-3], [#SERP-5].
Catalyst clock
2026-04-30
FY/Quarterly results and guidance update
Lead driver: Value · See fundamentals
Momentum
90
8% active weight
Current posture
7d trendImproving
Δ7d
+17.3
Δ21d
+24.7
Value
62
47% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
-1.3
Sentiment
29
45% active weight
Current posture
7d trendSoftening
Δ7d
-6.7
Δ21d
-18.0
Why this grade
Composite grade D. Momentum 90.2 / Value 61.8 / Sentiment 28.7
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-01-31. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$46.34
Analysis reference price unavailable
Analysis 2026-01-31 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$38.00
Analysis reference price unavailable
Analysis 2026-01-31 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-10-27
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$37.63B
Beta
0.41
Shares Out
446.62M
P/E (TTM)
22.7
P/S (TTM)
9.74
P/FCF (TTM)
40.35
Rev YoY
+16.5%
EPS YoY
-46.3%
Gross Margin
+99.8%
Op Margin
+62.3%
Net Debt
$8.33B
Current Ratio
2.80
As of 2026-10-27 • Updated nightlySource: Internal modelMethods & Data